MS33 is a VHL-recruiting PROTAC degrader targeting WDR5, a WD-repeat scaffold protein involved in chromatin-associated transcriptional regulation. Published work describes MS33 as an early WDR5 degrader lead and reports a high-resolution WDR5–MS33–VCB ternary-complex structure, making it an important example of structure-guided degrader development. In PROTAC design, the WDR5-binding moiety engages the target protein, the linker connects it to a VHL ligand, and the resulting ternary assembly positions WDR5 for ubiquitination. Mechanistically, MS33 induces VHL- and proteasome-dependent WDR5 degradation, supporting target depletion rather than simple inhibition of WDR5 interactions. It is useful for studying WDR5-dependent transcription, MLL-rearranged leukemia models, ternary-complex crystallography, linker optimization, VHL-based epigenetic degraders, and the transition from initial degrader leads to more potent structure-optimized analogs.
Structure of 2407449-11-8
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Target: MS33 targets WD repeat-containing protein 5, commonly abbreviated WDR5.
Binding site: Its WDR5 ligand binds the WIN site on the WDR5 β-propeller domain.
Mechanism of action: MS33 is a VHL-recruiting WDR5 PROTAC based on a WDR5-binding pharmacophore connected to a von Hippel-Lindau E3 ligase ligand. The compound forms a ternary WDR5–MS33–VCB complex, positioning WDR5 for ubiquitination and subsequent proteasome-mediated degradation. This mechanism removes WDR5 protein rather than only blocking its protein-protein interaction surfaces. MS33 is valuable for studying WDR5-dependent chromatin regulation, MYC- and MLL-associated transcriptional programs, and degradation-dependent phenotypes in leukemia or other WDR5-sensitive cellular models.
Applications• PROTAC-Mediated Kinase Degradation: MS33 is utilized to selectively degrade specific kinases, providing a powerful tool for dissecting kinase signaling pathways. This application enables researchers to study the dynamic roles of kinases in cellular processes by observing the downstream effects of their targeted removal.
• Targeted Degradation in Cancer Research: MS33 serves as a crucial agent in cancer research by facilitating the degradation of oncogenic proteins. This approach allows scientists to explore novel therapeutic strategies by eliminating proteins that drive tumor growth and survival, offering insights into potential interventions.
• PROTAC for Neurodegenerative Disease Studies: By employing MS33, researchers can target and degrade proteins implicated in neurodegenerative diseases. This application aids in understanding the pathological mechanisms of these diseases, potentially leading to the identification of new therapeutic targets through the removal of disease-associated proteins.
• Investigating Protein-Protein Interactions: MS33 is instrumental in studying protein-protein interactions by enabling the selective degradation of one interaction partner. This application helps elucidate the functional consequences of disrupting specific protein complexes, advancing our understanding of complex cellular networks.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.